144 related articles for article (PubMed ID: 32920892)
41. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
[TBL] [Abstract][Full Text] [Related]
42. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H
Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515
[TBL] [Abstract][Full Text] [Related]
43. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
[TBL] [Abstract][Full Text] [Related]
44. Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats.
Tanaka Y; Takagi R; Mitou S; Shimmura M; Hasegawa T; Amarume J; Shinohara M; Kageyama Y; Sasase T; Ohta T; Muramatsu SI; Kakehashi A; Kaburaki T
Biol Pharm Bull; 2024 Mar; 47(3):713-722. PubMed ID: 38432946
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.
Matsui K; Oda T; Nishizawa E; Sano R; Yamamoto H; Fukuda S; Sasase T; Miyajima K; Ueda N; Ishii Y; Ohta T; Matsushita M
Exp Anim; 2009 Jul; 58(4):363-74. PubMed ID: 19654434
[TBL] [Abstract][Full Text] [Related]
46. A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD Rats.
Li X; Wu M; Chen L; Lu J; Li G; Fu L; Qi N; Lin Y; Sun Z; Wang X; Zhang H; Liu J; Jiang H; Li L; Mei CL; Luo C
Am J Nephrol; 2020; 51(1):1-10. PubMed ID: 31694015
[TBL] [Abstract][Full Text] [Related]
47. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
48. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
49. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
[TBL] [Abstract][Full Text] [Related]
50. FTY720 Supplementation Partially Improves Erectile Dysfunction in Rats With Streptozotocin-Induced Type 1 Diabetes Through Inhibition of Endothelial Dysfunction and Corporal Fibrosis.
Cui K; Ruan Y; Wang T; Rao K; Chen Z; Wang S; Liu J
J Sex Med; 2017 Mar; 14(3):323-335. PubMed ID: 28162947
[TBL] [Abstract][Full Text] [Related]
51. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
Yang D; Sun YY; Bhaumik SK; Li Y; Baumann JM; Lin X; Zhang Y; Lin SH; Dunn RS; Liu CY; Shie FS; Lee YH; Wills-Karp M; Chougnet CA; Kallapur SG; Lewkowich IP; Lindquist DM; Murali-Krishna K; Kuan CY
J Neurosci; 2014 Dec; 34(49):16467-81. PubMed ID: 25471584
[TBL] [Abstract][Full Text] [Related]
52. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
[TBL] [Abstract][Full Text] [Related]
53. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Katsuda Y; Sasase T; Tadaki H; Mera Y; Motohashi Y; Kemmochi Y; Toyoda K; Kakimoto K; Kume S; Ohta T
Exp Anim; 2015; 64(2):161-9. PubMed ID: 25736710
[TBL] [Abstract][Full Text] [Related]
54. The spontaneously diabetic Torii rat with gastroenteropathy.
Yamada K; Hosokawa M; Fujimoto S; Nagashima K; Fukuda K; Fujiwara H; Ogawa E; Fujita Y; Ueda N; Matsuyama F; Yamada Y; Seino Y; Inagaki N
Diabetes Res Clin Pract; 2007 Feb; 75(2):127-34. PubMed ID: 16959364
[TBL] [Abstract][Full Text] [Related]
55. Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage.
Hasegawa Y; Uekawa K; Kawano T; Suzuki H; Kim-Mitsuyama S
Curr Drug Deliv; 2017 Sep; 14(6):861-866. PubMed ID: 27605019
[TBL] [Abstract][Full Text] [Related]
56. Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat.
Sasase T; Ohta T; Ogawa N; Miyajima K; Ito M; Yamamoto H; Morinaga H; Matsushita M
Diabetes Obes Metab; 2006 Sep; 8(5):501-7. PubMed ID: 16918584
[TBL] [Abstract][Full Text] [Related]
57. Effects of excessive sodium chloride loading in the spontaneously diabetic torii (SDT) fatty rats, a preclinical model of type 2 diabetes mellitus.
Teoh SH; Miyajima K; Shinozaki Y; Shinohara M; Ohata K; Briand F; Morimoto R; Nakamura Y; Uno K; Kemuriyama N; Nakae D; Ohta T; Maekawa T
J Toxicol Sci; 2021; 46(12):589-599. PubMed ID: 34853244
[TBL] [Abstract][Full Text] [Related]
58. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
59. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.
Foster CA; Mechtcheriakova D; Storch MK; Balatoni B; Howard LM; Bornancin F; Wlachos A; Sobanov J; Kinnunen A; Baumruker T
Brain Pathol; 2009 Apr; 19(2):254-66. PubMed ID: 18540945
[TBL] [Abstract][Full Text] [Related]
60. Identification of a major locus for islet inflammation and fibrosis in the spontaneously diabetic Torii rat.
Fuse M; Yokoi N; Shinohara M; Masuyama T; Kitazawa R; Kitazawa S; Seino S
Physiol Genomics; 2008 Sep; 35(1):96-105. PubMed ID: 18612083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
